Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease worldwide. The long-term impact of HCV infection is highly variable, ranging from minimal histological changes to extensive fibrosis and cirrhosis with or without hepatocellular carcinoma (HCC).... (read more by viewing or downloading EASL recommendations)
EASL HCV recommendations presented by Prof. Jean-Michel Pawlotsky at the International Liver Congress™ 2014, London, are now publicly available for the benefit of all.
Expert Panel Discussion, EASL Recommendations on the treatment of HCV, 2014
New study evaluates efficacy of PET imaging to manage chronic liver diseases
EASL governing board announces new Vice-Secretary
A web-based program is as effective as group counseling for patients with non-alcoholic fatty liver disease